Stock Events

Aspen Pharmacare 

ZAC19,928
21
-ZAC104-0.52% Friday 15:07

Statistics

Day High
20,268
Day Low
19,928
52W High
25,296
52W Low
16,096
Volume
871,178
Avg. Volume
1,206,596
Mkt Cap
65.2B
P/E Ratio
10.21
Dividend Yield
1.8%
Dividend
359

Upcoming

Dividends

1.8%Dividend Yield
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
11.07%
1Y Growth
4.97%

Earnings

3SepExpected
Q1 2020
Q2 2020
Q3 2020
Q4 2020
Q1 2021
Q4 2023
Q2 2024
0
0.18
0.37
0.55
Expected EPS
0.55146
Actual EPS
0.55146

People Also Follow

This list is based on the watchlists of people on Stock Events who follow APN.JO. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Pfizer
PFE
Mkt Cap164.39B
Pfizer is a global pharmaceutical company that competes with Aspen in various therapeutic areas, including anti-infectives and cardiovascular drugs.
Novartis
NVS
Mkt Cap244.75B
Novartis is a multinational pharmaceutical company that competes across several of the same therapeutic areas as Aspen, including generic medicines through its Sandoz division.
Johnson & Johnson
JNJ
Mkt Cap399.26B
Johnson & Johnson operates in the pharmaceutical sector with a broad range of products that compete with Aspen's portfolio, including in the areas of women's health and general medicines.
Merck
MRK
Mkt Cap300.25B
Merck is a global healthcare company that competes with Aspen, particularly in the areas of infectious diseases and cardiovascular health.
GSK
GSK
Mkt Cap89.55B
GlaxoSmithKline competes with Aspen in the development and marketing of pharmaceuticals and vaccines, including in respiratory diseases and HIV.
Abbvie
ABBV
Mkt Cap346.75B
AbbVie competes with Aspen in the pharmaceutical sector, particularly in the areas of immunology and oncology, areas Aspen is expanding into.
Sanofi
SNY
Mkt Cap141.43B
Sanofi competes with Aspen, offering a broad portfolio of drugs that overlap with Aspen's, including in the areas of cardiovascular diseases and central nervous system disorders.
Teva- Pharmaceutical Industries
TEVA
Mkt Cap21.38B
Teva Pharmaceutical Industries is a leading generic pharmaceutical company that competes with Aspen's manufacturing and distribution of generic medicines.
Astrazeneca
AZN
Mkt Cap271.67B
AstraZeneca competes with Aspen in several therapeutic areas, including respiratory, cardiovascular, and metabolic diseases, areas where Aspen also operates.

About

Aspen Pharmacare Holdings Limited, together with its subsidiaries, manufactures and supplies specialty and branded pharmaceutical products worldwide. It operates in Commercial Pharmaceuticals and Manufacturing segments. The company provides general anesthetics, muscle relaxants, and topical agents under the Anaesthetics brand; and a range of injectable anticoagulants with a focus on low molecular weight heparins, Xa inhibitors, and heparin derivatives under the Thrombosis brand. It also offers branded consumer, prescription, and over-the-counter products under the regional brands, such as Circadin, Foxair, Maltofer, Mybulen, and Zyloric for various types of anesthetic comprises sleeping aid, respiratory, iron supplement, analgesic, and uric acid production inhibitor. In addition, the company manufactures and sells active pharmaceutical ingredients and finished dose form products to third-party customers. Aspen Pharmacare Holdings Limited was founded in 1850 and is headquartered in Durban, South Africa.
Show more...
CEO
Mr. Stephen Bradley Saad
Employees
8580
Country
South Africa
ISIN
ZAE000066692

Listings